Journal Logo

Articles by M. Abbenante

A NEW BIOMARKER OF RESPONSE TO 5-AZACITIDINE THERAPY IN MDS AND AML PATIENTS: SIRPB1: PS997

Cerchione, C.; Guadagnuolo, V.; Papayannidis, C.; More

HemaSphere. 3:448-449, June 2019.